Global market for biosimilars to grow to $3.6 billion by 2016

The global market for biosimilars reached $1.7 billion in 2010 and $2.5 billion in 2011. The market is expected to reach $3.6 billion by 2016, a compound annual growth rate (CAGR) of 7.7%.

Learn about global markets for biosimilars and biosimilar product classes. This report also covers various regional markets and includes information on technology trends and patents analysis. Company profiles are included as well...

USE THIS REPORT TO:

• Receive an in-depth look at the demand for biosimilar drugs that have entered the global market and forecasts for the potential growth of these products
• Receive detailed analysis of the emerging regulatory framework in controlled markets including patent analysis and technology trends
• Analyze pricing trends, technology advancements, and their effects on the affordability of biosimilars
• Receive information about key players in various regional markets, rising investments, and the financial environment of the sector.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

GLOBAL BIOSIMILAR DEMAND BY VALUE AND PRODUCT TYPE, 2011

(PERCENT)